Zymeworks Common Stock Options

ZYME Stock  USD 14.46  0.55  3.66%   
Zymeworks Common's latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.52. The Zymeworks Common option chain provides detailed quote and price information for the current Zymeworks Common Stock option contracts. It shows all of Zymeworks Common's listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on Zymeworks Common

Analyzing Zymeworks Common's in-the-money options over time can help investors to take a profitable long position in Zymeworks Common regardless of its overall volatility. This is especially true when Zymeworks Common's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Zymeworks Common's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Zymeworks Common's stock while costing only a fraction of its price.
Zymeworks Common's stock options are financial instruments that give investors the right to buy or sell shares of Zymeworks Common Stock common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Zymeworks stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Zymeworks Common's stock price goes up or down, the stock options follow.
At present, Zymeworks Common's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 171.8 M, whereas Preferred Stock Total Equity is forecasted to decline to about 47.1 M.

Zymeworks Current Options Market Mood

Zymeworks Common's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Zymeworks Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most Zymeworks Common's options investors are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Zymeworks Common's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Zymeworks Common's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Zymeworks contract

Base on the Rule 16, the options market is currently suggesting that Zymeworks Common Stock will have an average daily up or down price movement of about 0.0325% per day over the life of the 2025-01-17 option contract. With Zymeworks Common trading at USD 14.46, that is roughly USD 0.0047. If you think that the market is fully incorporating Zymeworks Common's daily price movement you should consider buying Zymeworks Common Stock options at the current volatility level of 0.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Zymeworks Common options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Zymeworks calls. Remember, the seller must deliver Zymeworks Common Stock stock to the call owner when a call is exercised.

Zymeworks Common Option Chain

When Zymeworks Common's strike price is surpassing the current stock price, the option contract against Zymeworks Common Stock stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Zymeworks Common's option chain is a display of a range of information that helps investors for ways to trade options on Zymeworks. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Zymeworks. It also shows strike prices and maturity days for a Zymeworks Common against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
ZYME250117C0000250002.54.5 - 9.04.5Out
Call
ZYME250117C0000500005.02.5 - 7.02.5Out
Call
ZYME250117C0000750007.50.9 - 5.40.9Out
Call
ZYME250117C00010000010.00.25 - 4.80.25Out
Call
ZYME250117C00012500012.50.0 - 5.05.0Out
Call
ZYME250117C00015000015.00.0 - 5.05.0Out
Call
ZYME250117C00017500017.50.0 - 5.05.0Out
Call
ZYME250117C00020000020.00.0 - 0.850.85Out
Call
ZYME250117C00022500022.50.0 - 0.70.7Out
Call
ZYME250117C00025000025.00.0 - 3.83.8Out
 Put
ZYME250117P0000250002.50.0 - 5.05.0Out
 Put
ZYME250117P0000500005.00.0 - 5.05.0Out
 Put
ZYME250117P0000750007.50.0 - 5.05.0Out
 Put
ZYME250117P00010000010.00.35 - 4.90.35Out
 Put
ZYME250117P00012500012.52.4 - 6.82.4Out
 Put
ZYME250117P00015000015.04.3 - 9.04.3Out
 Put
ZYME250117P00017500017.56.5 - 11.06.5Out
 Put
ZYME250117P00020000020.09.3 - 12.19.3Out
 Put
ZYME250117P00022500022.58.7 - 13.58.7Out
 Put
ZYME250117P00025000025.09.7 - 14.59.7Out

Zymeworks Common Market Cap Over Time

   Market Cap   
       Timeline  

Zymeworks Total Stockholder Equity

Total Stockholder Equity

561.25 Million

At present, Zymeworks Common's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Zymeworks Common Corporate Directors

Thomas KreudensteinDirector EngineeringProfile
Nina WeisserDirector TherapeuticsProfile
Lota ZothLead Independent DirectorProfile
Shrinal InamdarDirector RelationsProfile
When determining whether Zymeworks Common Stock is a strong investment it is important to analyze Zymeworks Common's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zymeworks Common's future performance. For an informed investment choice regarding Zymeworks Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zymeworks Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zymeworks Common. If investors know Zymeworks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zymeworks Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.49)
Revenue Per Share
0.831
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.15)
Return On Equity
(0.29)
The market value of Zymeworks Common Stock is measured differently than its book value, which is the value of Zymeworks that is recorded on the company's balance sheet. Investors also form their own opinion of Zymeworks Common's value that differs from its market value or its book value, called intrinsic value, which is Zymeworks Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zymeworks Common's market value can be influenced by many factors that don't directly affect Zymeworks Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zymeworks Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zymeworks Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zymeworks Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.